Jushi Holdings Inc. SEC filings JUSH
Jushi Holdings Inc. has 245 filings in SEC EDGAR's recent list, going back to May 16, 2022. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| S-8 | Employee stock plan registration | Aug 28, 2026 | — |
| EFFECT | Filing | Aug 3, 2026 | — |
| EFFECT | Filing | Aug 3, 2026 | — |
| POS AM | Filing | Jul 31, 2026 | — |
| POS AM | Filing | Jul 31, 2026 | — |
| S-8 POS | S-8 | Jul 31, 2026 | — |
| 8-K12G3 | Filing | Jul 31, 2026 | Jul 30, 2026 |
| 10-Q | Quarterly report | Jul 28, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 24, 2026 | Jun 24, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | May 11, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | May 11, 2026 | — |
| DEF 14A | Proxy statement | May 11, 2026 | Jun 24, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 24, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Other events
|
Apr 24, 2026 | Apr 24, 2026 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| 10-K/A | Amended annual report | Apr 14, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Sep 22, 2025 | Sep 18, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 3, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 3, 2025 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Mar 3, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2025 | Jan 6, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 424B3 | Prospectus | Sep 18, 2024 | — |
| 8-K |
Current report
New debt, Officer or director change, Other events
|
Sep 18, 2024 | Sep 13, 2024 |
| EFFECT | Filing | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 11, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2024 | — |
| S-3 | Shelf registration | Aug 30, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 23, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| D | Filing | Aug 15, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, New debt, Unregistered share sale
|
Aug 6, 2024 | Jul 31, 2024 |
| CORRESP | Letter to the SEC | Aug 1, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2024 | — |
| CORRESP | Letter to the SEC | Jun 28, 2024 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 4, 2024 | Jun 4, 2024 |
| UPLOAD | Letter from the SEC | May 21, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 424B3 | Prospectus | May 6, 2024 | — |
| EFFECT | Filing | Apr 30, 2024 | — |
| CORRESP | Letter to the SEC | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 4, 2024 |
| UPLOAD | Letter from the SEC | Apr 23, 2024 | — |
| S-3 | Shelf registration | Apr 16, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2024 | Apr 12, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2024 | Mar 19, 2024 |
| NT 10-K | Filing | Mar 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
New debt, Unregistered share sale
|
Jan 30, 2024 | Jan 24, 2024 |
| 8-K |
Current report
New debt, Unregistered share sale, Officer or director change
|
Nov 16, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 30, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 14, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2023 | May 17, 2023 |
| EFFECT | Filing | May 16, 2023 | — |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| POS AM | Filing | May 12, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Auditor change, Regulation FD disclosure
|
Apr 25, 2023 | Apr 19, 2023 |
| 10-K | Annual report | Apr 18, 2023 | Dec 31, 2022 |
| 424B3 | Prospectus | Apr 12, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Apr 12, 2023 | Apr 6, 2023 |
| 424B3 | Prospectus | Apr 3, 2023 | — |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2023 | Mar 31, 2023 |
| 424B3 | Prospectus | Mar 20, 2023 | — |
| 8-K |
Current report
New debt, Unregistered share sale, Officer or director change
|
Mar 17, 2023 | Mar 14, 2023 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Feb 16, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 13, 2023 | Feb 13, 2023 |
| 424B3 | Prospectus | Jan 23, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Jan 20, 2023 | Jan 16, 2023 |
| 424B3 | Prospectus | Jan 13, 2023 | — |
| 8-K |
Current report
Other events
|
Jan 13, 2023 | Jan 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 9, 2023 | Jan 6, 2023 |
| D | Filing | Dec 22, 2022 | — |
| 424B3 | Prospectus | Dec 16, 2022 | — |
| 8-K |
Current report
New debt, Unregistered share sale
|
Dec 15, 2022 | Dec 9, 2022 |
| 424B3 | Prospectus | Dec 9, 2022 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure
|
Dec 8, 2022 | Dec 7, 2022 |
| S-8 | Employee stock plan registration | Nov 28, 2022 | — |
| 424B3 | Prospectus | Nov 22, 2022 | — |
| 10-Q | Quarterly report | Nov 21, 2022 | Sep 30, 2022 |
| NT 10-Q | Filing | Nov 15, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Nov 15, 2022 | Nov 15, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 424B3 | Prospectus | Oct 7, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2022 | Oct 3, 2022 |
| 424B3 | Prospectus | Sep 29, 2022 | — |
| 424B3 | Prospectus | Sep 29, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2022 | Sep 26, 2022 |
| 10-Q | Quarterly report | Sep 26, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Sep 12, 2022 | Sep 9, 2022 |
| 8-K |
Current report
Results of operations, Restatement, Officer or director change, Regulation FD disclosure
|
Aug 29, 2022 | Aug 29, 2022 |
| 424B3 | Prospectus | Aug 15, 2022 | — |
| EFFECT | Filing | Aug 12, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| 8-A12G | Form 8-a12g | Aug 10, 2022 | — |
| S-1/A | Amended registration statement | Aug 8, 2022 | — |
| S-1 | Registration statement | Jul 22, 2022 | — |
| CORRESP | Letter to the SEC | Jul 22, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2022 | — |
| DRS/A | Filing | Jul 7, 2022 | — |
| DRSLTR | Filing | Jul 6, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2022 | — |
| DRS | Filing | May 17, 2022 | — |
| DRSLTR | Filing | May 16, 2022 | — |
Showing 141 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- JUSH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1909747
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.